RXRX - RECURSION PHARMACEUTICALS, INC.
3.64
0.100 2.747%
Share volume: 16,101,964
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$3.54
0.10
0.03%
Summary score
34%
Profitability
35%
Dept financing
25%
Liquidity
58%
Performance
31%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-16.6%
Return on assets
-12.04%
Return on sales
-1116.68%
Return on invested capital
-128.23%
Total debt ratio
29.45%
Debt ratio change over timeo
-1.27%
Current Ratio
5.04%
Quick Ratio
5.24%
Cash Position Ratio
4.53%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-11.48%
Return on sales
-1643.42%
Return on invested capital
0%
Total debt ratio
25.64%
Debt ratio change over timeo
0%
Current Ratio
4.74%
Quick Ratio
0%
Cash Position Ratio
4.27%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-7.33%
Return on sales
-304.84%
Return on invested capital
0%
Total debt ratio
23.29%
Debt ratio change over time
0%
Current Ratio
5.5%
Quick Ratio
0%
Cash Position Ratio
5.03%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-84.55%
Return on assets
-87.82%
Return on sales
600.36%
Return on invested capital
-7.64%
Total debt ratio
-127.28%
Debt ratio change over time
-1.27%
Current Ratio
-5.73%
Quick Ratio
-5.23%
Cash Position Ratio
-5.29%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RXRX | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -16.6% | 0% | 5.97% | 8.91% |
| Return on assets | -12.04% | 2.97% | 3.34% | 2.04% |
| Return on sales | -1116.68% | 27.71% | 27.82% | 21.49% |
| Return on invested capital | -128.23% | 0% | 3.51% | 10.25% |
| Profitability | 0% | 47% | 75% | 85% |
| Total debt ratio | 29.45% | 93.27% | 65.75% | 43.64% |
| Debt ratio change over time | -1.27% | 14.34% | 187.33% | 9.75% |
| Dept financing | 8% | 27% | 43% | 13% |
| Current Ratio | 4.74% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 0% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 4.27% | 0.39% | 0.58% | 0.86% |
| Liquididy | 75% | 19% | 15% | 23% |
| Short-term ratios | RXRX | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -11.48% | 3.27% | 4.7% | 1.36% |
| Return on sales | -1643.42% | 24.35% | 34.09% | 15.11% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 35% | 50% | 18% |
| Total debt ratio | 25.64% | 91.09% | 63.87% | 38.21% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 32% | 25% | 18% | 10% |
| Current Ratio | 4.74% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 0% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 4.27% | 0.39% | 0.58% | 0.86% |
| Liquididy | 50% | 22% | 29% | 42% |